Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
IQ U.S. Large Cap R&D Leaders ETF LRND
$20.96
-$0.98 (-4.67%)
На 17:51, 12 мая 2023
Ключевые показатели
-
Marketcap
0.00000000
-
week52high
25.80
-
week52low
19.10
-
Revenue
-
P/E TTM
-
Beta
0.00000000
-
EPS
1.04587710
-
Last Dividend
0.31300000
-
Next Earnings Date
07 мая 2023 г. в 09:21
Описание компании
The underlying index seeks to provide exposure to innovative companies by investing in the equities of U.S. large cap companies that have high research and development ("R&D") spending. The fund invests, under normal circumstances, at least 80% of its net assets, plus the amount of any borrowings for investment purposes, in the investments included in its underlying index. The fund is non-diversified.
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
Bet on R&D With These New ETFs
Zacks Investment Research
27 окт 2022 г. в 14:18
We have recently received three new ETFs built on the concept of R&D.
IndexIQ Launches R&D-Focused ETF Trio
ETFcom
08 февр 2022 г. в 12:37
New York Life's ETF brand is targeting companies that spend big on research.
IndexIQ Launches Trio of Growth ETFs
ETF Trends
08 февр 2022 г. в 11:35
IndexIQ has expanded its ETF product lineup with the launch of three new equity-focused strategies. The new trio of funds — the IQ U.S. Large Cap R&D Leaders ETF (LRND), the IQ U.S. Mid Cap R&D Leaders ETF (MRND), and the IQ Global Equity R&D Leaders ETF (WRND) — launched on the NYSE on February 8.